C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages.

J Immunol

School of Biomedical Sciences, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia

Published: August 2020

The complement activation fragment C5a is a potent proinflammatory mediator that is increasingly recognized as an immune modulator. C5a acts through two C5a receptors, C5aR1 (C5aR, CD88) and C5aR2 (C5L2, GPR77), to powerfully modify multiple aspects of immune cell function. Although C5aR1 is generally acknowledged to be proinflammatory and immune-activating, the potential roles played by C5aR2 remain poorly defined. Despite studies demonstrating C5aR2 can modulate C5aR1 in human cells, it is not yet known whether C5aR2 functionality is limited to, or requires, C5aR1 activation or influences immune cells more broadly. The present study, therefore, aimed to characterize the roles of C5aR2 on the signaling and function of primary human monocyte-derived macrophages, using a C5aR2 agonist (Ac-RHYPYWR-OH; P32) to selectively activate the receptor. We found that although C5aR2 activation with P32 by itself was devoid of any detectable MAPK signaling activities, C5aR2 agonism significantly dampened C5aR1-, C3aR-, and chemokine-like receptor 1 (CMKLR1)-mediated ERK signaling and altered intracellular calcium mobilization mediated by these receptors. Functionally, selective C5aR2 activation also downregulated cytokine production triggered by various TLRs (TLR2, TLR3, TLR4, and TLR7), C-type lectin receptors (Dectin-1, Dectin-2, and Mincle), and the cytosolic DNA sensor stimulator of IFN genes (STING). Surprisingly, activity at the C-type lectin receptors was particularly powerful, with C5aR2 activation reducing Mincle-mediated IL-6 and TNF-α generation by 80-90%. In sum, this study demonstrates that C5aR2 possesses pleiotropic functions in primary human macrophages, highlighting the role of C5aR2 as a powerful regulator of innate immune function.

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.2000407DOI Listing

Publication Analysis

Top Keywords

c5ar2 activation
16
c5ar2
13
primary human
12
signaling function
8
function primary
8
human macrophages
8
c-type lectin
8
lectin receptors
8
activation
5
activation broadly
4

Similar Publications

The interaction of methotrexate with the human C5a and its potential therapeutic implications.

Comput Biol Chem

February 2025

Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Odisha 752050, India. Electronic address:

Methotrexate (MTX) is an antimetabolite drug that mimics folate and inhibits dihydrofolic acid reductase, resulting in the impairment of malignant growth in actively proliferating tissues. MTX is approved by the FDA for primarily treating non-Hodgkin lymphoma, lymphoblastic leukemia, and osteosarcoma. In addition, MTX is also prescribed as a preferred anti-rheumatic medication for the management of rheumatoid arthritis, including psoriasis, indicating that MTX has a multipronged mechanism of action.

View Article and Find Full Text PDF
Article Synopsis
  • C5aR2, a receptor for C5a, is being studied for its complex roles in modulating the classic receptor C5aR1, particularly under normal and inflammatory conditions.
  • Research shows that C5aR2 knockout in mice does not affect the expression of C5aR1 mRNA levels in various immune cells, but it reduces the surface expression of C5aR1 on neutrophils, possibly due to altered internalization.
  • The study suggests that C5aR2 may antagonize C5aR1's signaling in neutrophils and work alongside it in macrophages, indicating distinct functions of C5aR2 across different cell types.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of C5aR2, a receptor related to inflammation, in hypertension and its effects on kidney injury, revealing that C5aR2 deficiency does not impact hypertensive damage caused by angiotensin II in mice.
  • C5aR2 expression is primarily found in immune cells like dendritic cells and monocytes, both in mice and hypertensive human patients, suggesting a potential link between immune response and hypertension.
  • Despite the high expression of C5aR2 in these immune cells, results indicate that its absence does not lead to differences in blood pressure or renal and cardiac injuries in models of hypertension induced by angiotensin II.
View Article and Find Full Text PDF

Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19.

Arterioscler Thromb Vasc Biol

May 2024

Metabolism and Lipids Unit, Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, NY (Q.C., R.S.R.).

Article Synopsis
  • SARS-CoV-2 infections, which cause COVID-19, lead to inflammation and increased risk of blood clots, with myeloid cells playing a key role in the immune response.
  • The study examined the immune responses in patients with severe and mild COVID-19 using advanced techniques like proteomics and transcriptomics, revealing different levels of inflammatory and vascular markers.
  • Findings showed that severe COVID-19 patients had higher levels of certain markers and displayed immune response abnormalities, indicating a complex relationship between inflammation and coagulation issues in the disease.
View Article and Find Full Text PDF

The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation.

Nephron

October 2024

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.

The complement system, a cornerstone of the innate immune defense, typically confers protection against pathogens. However, in various clinical scenarios the complement's defensive actions can harm host cells, exacerbating immune and inflammatory responses. The central components C3 and C5 undergo proteolytic cleavage during complement activation, yielding small active fragments C3a and C5a anaphylatoxins.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!